Displaying 101–125 of 251 results for Paul Thomas, Senior Editor

Sort By Relevance Sort By Date
1... 3 4 5 6 7 ...11

Behind Closed Doors: How FDA, EMA, and TGA Partner

(Article)

FDA's liaison in Europe, Janice Soreth, discusses international harmonization and the API joint inspection pilot project.

Building a Culture of Training: Best Practices from Shire HGT

(Article)

A discussion with Bill Ciambrone, Senior Vice President of Technical Operations for Shire Human Genetic Therapies, about critical issues in workforce training today.

Workforce Training: Embracing the "Necessary Evil"

(Article)

As FDA probes the connection between workforce training and quality, manufacturers must do the same.

Temporary Workers: Pharma's Contingency Planning

(Article)

Consultant Steve Sawin answers our questions about managing contingent labor.

Pharma Suppliers See Training as Competitive Advantage

(Article)

As drug manufacturers struggle to train their workers, solution providers step in to help.

Reducing Variability in the Pharma Workforce

(Article)

How drug manufacturers can overcome the "44th Hour Problem" and other challenges associated with a variable workforce.

PharmaView: Our Employability Challenge

(Article)

It may be hard to find good help, but it’s also hard to find good work.

The Cutting Edge of Continuous

(Article)

Manufacturers look outside their walls for flow chemistry expertise.

PharmaView: Where Everybody Knows Your Name

(Article)

If Ashton Kutcher were in pharma, he’d be on LinkedIn.

Microbial ID Habits, Under the Microscope

(Article)

A look at what microbiologists do and want, by the numbers, and commentary from consultant Pascal Yvon.

From Go-Karts to Formula 1: Distinguishing True Digital Signatures

(Article)

Digital signatures have grown in sophistication and import, becoming a staple of serious and compliant drug manufacturers, explains SAFE-Biopharma's Mollie Shields-Uehling.

The Evolving LIMS, and What It Means for the Pharmaceutical Lab

(Article)

A look into the laboratory's integrated, and on-demand, future with Thermo Fisher expert Kim Shah.

Drugs in Wastewater: A Call for More Research, More Responsibility

(Article)

Manufacturers must practice a heightened sense of "Pharmecovigilance" regarding drug compounds leaving their facilities as waste, says a leading expert.

PharmaView: What's In Your Wastewater? It's Time to Find Out

(Article)

We have little grasp of the downstream impact of API's being discharged from our facilities.

Podcast: API Pollution: Are Drug Manufacturers Trying to Stymie Studies?

(Multimedia)

A recent U.S. Geological Survey study found two drug facilities in New York state releasing high levels of API into local groundwater. The manufacturers have been less than cooperative, says study lead Patrick Phillips, speaking with Senior Editor Paul Thomas. Without adequate studies, Phillips ...

From SharePoint to Cloud Computing: Microsoft's Life Sciences Evolution

(Multimedia)

Microsoft is positioning SharePoint as a solution to the industry's innovation gap. In this interview with Senior Editor Paul Thomas at DIA 2010, Michael Naimoli, Director of Life Sciences Industry Solutions, discusses how manufacturers like GSK and Merck are using SharePoint as a knowledge ...

Contract Manufacturing: Orchestrating the Dance

(Article)

Lean Six Sigma, expertise in microbiology, and shop-floor experience all contribute to running a flexible, efficient contract facility, says DPT’s new director of sterile ops.

PharmaView: Continuous Processes Find Their Flow in Pharma

(Article)

Is pharma's transformation from a batch-only universe now upon us?

Supplier Audits: Drawing ROI from a Trusted Community

(Article)

If supplier audits could be harmonized and shared amongst trusted partners, "we could effectively revolutionize the entire industry" and make our supply chains much safer, says Sigma-Aldrich's Tom Beil.

Leaning QC: Lonza Rolls Out Raman for Materials ID

(Article)

After evaluating technologies, Lonza Biologics is implementing a Raman-based raw materials identification process. QC manager Derek Hubley explains why, and how.

Condition Monitoring: Try Not To Be Alarmed

(Article)

With real-time, wireless and other new monitoring technologies, pharma gains better control of temperature, pressure, humidity, and more.

Abbott's Bridge to ASTM Risk-Based Commissioning and Qualification

(Article)

A gradual transition to better C&Q practices is warranted, as is "getting rid of wasteful, bureaucratic practices that have developed over the years," says Abbott's David Dolgin.

Green Processes: PAT and QbD Take Root

(Article)

Leveraging PAT and QbD promises significant environmental dividends

PharmaView: Bringing a Drug to Market, in a Semester's Time

(Article)

Feeding the minds of tomorrow's science-based professionals . . . with cookies.

Sort By Relevance Sort By Date
1... 3 4 5 6 7 ...11